Luke Nordquist, MD, FACP, CEO
drluke@xcancer.comTony Romero, MS, CCRC, Director of Research
tromero@gucancer.comDescription:
This is an open-label whole-body PET/CT study for investigating the value of Al18F-NOTA-FAPI PET/CT in patients with malignant tumors expressing fibroblast-activated proteins
Sponsor:
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Contacts:
Gouzhu (Hou)15611145656@163.com
15611145656
Xin (Cheng)cxpumc@foxmail.com
15120002998
Government Study Link:
NCT05749302 - Click here to see study onClinicalTrials.gov
Help us improve your experience